Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

The Trump administration has revoked several Biden-era health directives in a flurry of late night activity March 14. | President Trump took another step in dismantling Biden's health policy legacy by ...